Op.Dr.Gökhan ATEŞ — Antalya Obezite CerrahisiOp.Dr.Gökhan ATEŞ
Treatment Options

GLP-1 Medications vs. Bariatric Surgery: How to Compare

GLP-1 receptor agonists (e.g. semaglutide, tirzepatide) have changed the obesity-treatment landscape. They are not a replacement for surgery in every patient, but they are an important option — sometimes alongside surgery.

Typical Weight Loss

GLP-1 medications produce average total body weight loss in the 10–20% range in trials. Bariatric surgery typically produces 25–35% total body weight loss with greater durability at 5+ years in the average patient.

Metabolic Effects

Both improve type 2 diabetes, blood pressure, and lipid profile. Surgery — especially bypass procedures — shows higher rates of diabetes remission in patients with shorter disease duration.

Durability and Cost

Medication effect depends on continuous use; discontinuation typically leads to weight regain. Surgery is a one-time intervention with lifelong follow-up. Cost models differ significantly by country.

Combined Use

GLP-1 medication can be considered before surgery (selected patients), or after surgery in cases of insufficient response or weight regain. Decisions are individualised within the bariatric team.

References

  • Eisenberg D et al., 2022 ASMBS/IFSO Indications
  • STEP and SURMOUNT trial programmes
Medical notice: The information on this page is for general patient education only and does not replace medical diagnosis, treatment, or a surgical decision. The appropriate method for you can only be determined after a physician's assessment and necessary tests.

Last updated: 28.06.2026 · Medical content: Op.Dr.Gökhan ATEŞ

Request a Preliminary Assessment All articles